Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D-3 in human malignant melanoma cell lines

被引:88
|
作者
Evans, SRT
Houghton, AM
Schumaker, L
Brenner, RV
Buras, RR
Davoodi, F
Nauta, RJ
Shabahang, M
机构
[1] Department of Surgery, Lombardi Cancer Center, Georgetown University Hospital, Washington
[2] Department of Surgery, 4 PHC, Georgetown University Hospital, Washington, DC 20007, 3800 Reservoir Road, N.W
关键词
D O I
10.1006/jsre.1996.0092
中图分类号
R61 [外科手术学];
学科分类号
摘要
The expression of vitamin D receptors (VDR) and growth inhibition induced by 1,25-dihydroxyvitamin D-3 have been noted in certain human malignant melanoma cell lines. In this study, widely disparate levels of VDR mRNA expression were demonstrated in a panel of eight human malignant melanoma cell lines. Quantitation of receptor level by ligand binding assay showed a similar pattern. Proliferation and growth curve analysis was performed in two cell lines: RPMI 7951 (high VDR) and SK-MEL-28 (low VDR). Significant growth inhibition was noted in RPMI 7951 cells at 10(-9) M 1,25-dihydroxyvitamin Ds SK-MEL-28 cells, which express much lower levels of VDR, did not show any growth inhibition except at extremely high concentrations of 1,25-dihydroxyvitamin D-3, namely 10(-6) M. These findings suggest a receptor-mediated mechanism of growth inhibition for 1,25-dihydroxyvitamin Ds and a role for this hormone in the growth of malignant melanoma cells. (C) 1996 Academic Press, Inc.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 50 条
  • [31] REGULATION OF HUMAN PLACENTAL-LACTOGEN EXPRESSION BY 1,25-DIHYDROXYVITAMIN D-3
    STEPHANOU, A
    ROSS, R
    HANDWERGER, S
    ENDOCRINOLOGY, 1994, 135 (06) : 2651 - 2656
  • [32] METABOLISM OF 1,25-DIHYDROXYVITAMIN D-3 IN A HUMAN CHRONIC MYELOGENOUS LEUKEMIC-CELL LINE
    REDDY, GS
    LASKY, SR
    EIL, C
    SANTOS, A
    KUMAR, M
    CLARK, J
    PEDIATRIC RESEARCH, 1991, 29 (04) : A198 - A198
  • [33] Stability of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in human serum
    El-Khoury, Joe M.
    Wang, Sihe
    CLINICAL BIOCHEMISTRY, 2012, 45 (09) : 707 - 708
  • [34] The 1,25-dihydroxyvitamin D-3 analog KH1060 induces a conformational change and enhanced stabilization of the vitamin D receptor
    vandenBemd, GJCM
    Pols, HAP
    Birkenhager, JC
    Prahl, JM
    DeLuca, HF
    vanLeeuwen, JPTM
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : S474 - S474
  • [35] 1,25-DIHYDROXYVITAMIN D-3 AND 22-OXA-1,25-DIHYDROXYVITAMIN D-3 IN-VIVO NUCLEAR RECEPTOR-BINDING IN DEVELOPING BONE DURING ENDOCHONDRAL AND INTRAMEMBRANOUS OSSIFICATION
    STUMPF, WE
    KOIKE, N
    HAYAKAWA, N
    TOKUDA, K
    NISHIMIYA, K
    TSUCHIYA, Y
    HIRATE, J
    OKAZAKI, A
    KUMAKI, K
    HISTOCHEMISTRY, 1994, 102 (03) : 183 - 194
  • [36] 1,25-DIHYDROXYVITAMIN D-3 POTENTIATES THE KERATINOCYTE RESPONSE TO CALCIUM
    SU, MJ
    BIKLE, DD
    MANCIANTI, ML
    PILLAI, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (20) : 14723 - 14729
  • [37] Squamous carcinoma cell lines fail to respond to 1,25-dihydroxyvitamin D despite normal levels of the vitamin D receptor
    Ratnam, AV
    Bikle, DD
    Su, MJ
    Pillai, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (03) : 522 - 525
  • [38] Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3
    Colin, EM
    Weel, AEAM
    Uitterlinden, AG
    Buurman, CJ
    Birkenhäger, JC
    Pols, HAP
    van Leeuwen, JPTM
    van Leeuwen,
    CLINICAL ENDOCRINOLOGY, 2000, 52 (02) : 211 - 216
  • [39] Apparent nonnuclear regulation of intestinal phosphate transport: Effects of 1,25-dihydroxyvitamin D-3, 24,25-dihydroxyvitamin D-3, and 25-hydroxyvitamin D-3
    Nemere, I
    ENDOCRINOLOGY, 1996, 137 (06) : 2254 - 2261
  • [40] Salt concentration determines 1,25-dihydroxyvitamin D-3 dependency of vitamin D receptor retinoid X receptor vitamin D-responsive element complex formation
    KimmelJehan, C
    Jehan, F
    DeLuca, HF
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 341 (01) : 75 - 80